BECN1 and neoplasm: There is a strong connection between BECN1-mediated autophagy and the hypoxic conditions commonly present in the tumor microenvironment (TME), which in turn contributes to resistance against broad-spectrum anticancer drugs, such as bevacizumab [21,22].